Senior insider sale
VP, Corp Controller and CAO at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$2.52M
70.03K shares
What this filing means
CALVIN SANDRA plans to sell 70.03K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $2.52M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/15/2025ACC: 0001950047-25-010276
Officer· VP, Corp Controller and CAO
Since Sep 2021
70.03K
Shares to sell
$2.52M
Approx. market value
2.91K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercised Shares
Cash
11/25/2024
2.91KTotal acquired2.91K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/25/2024 | Exercised Shares Cash | 2.91K | — |
| Total | 2.91K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
67.11K
Market value
$2.42M
11/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.91K
Market value
$104.8K
12/15/2025
Total
Units
70.03K
Value
$2.52M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/4/2025 | 67.11K | $2.42M | — | Completed |
| Planned — Approximate Date | ||||
12/15/2025 | 2.91K | $104.8K | NASDAQ | Planned |
| Total | 70.03K | $2.52M | ||